AVTX-002
AVTX-002-NEA-201
Phase 2 small_molecule completed
Quick answer
AVTX-002 for Non-Eosinophilic Asthma is a Phase 2 program (small_molecule) at Avalo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Avalo Therapeutics
- Indication
- Non-Eosinophilic Asthma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed